Interview with Cathal Friel, Chair & Co-Founder of hVIVO PLC, by Brian Egan, Partner at KPMG Ireland Discover how to scale a company from startup to billion-euro enterprise with Cathal
Interview with Cathal Friel, Chair & Co-Founder of hVIVO PLC, by Brian Egan, Partner at KPMG Ireland Discover how to scale a company from startup to billion-euro enterprise with Cathal
hVIVO plc (AIM: HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that the Company has granted
Helix Exploration (HEX), the helium exploration and development company, provided an operational update on the Clink #1 well at the Ingomar Dome Project. HEX said Precision Drilling Rig 704 has commenced
Positive results from RSV antiviral human challenge trial conducted by hVIVO Larger human challenge trial provides valuable insights for candidate development
Official launch of full suite of hLAB standalone services Health & Safety Executive (HSE) clearance received for containment level 3 (CL-3) laboratory
Ondine Biomedical (OBI), a Canadian life sciences company pioneering light-activated antimicrobial treatments, announced that it has agreed to a private placement financing in exchange for common shares from a new third-party
European Green Transition (AIM: EGT), a company developing green economy assets in Europe which aims to capitalise on the opportunities created by the green energy transition, is pleased to announce its unaudited
Zephyr Energy (ZPHR), the Rocky Mountain oil and gas company focused on responsible resource development and carbon-neutral operations, noted recent market speculation that the Company is in the process of, or
Technology Minerals (TM1), the UK firm establishing a circular economy for battery metals, announced that it is carrying out a cost reduction programme to enhance efficiencies throughout the business and focus
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Avacta, Audioboom,
hVIVO (HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its unaudited interim results for the
The exceptional operational delivery across the Group in H1 24 resulted in record revenues of £35.6m, 30.6% higher than H1 2023.